Medication adherence and treatment success in patients with tuberculosis Infections and Infestations
Conditions
Interventions
A total of 38 health centers was randomly selected and allocated to the intervention (n = 19) and the control group (n = 19) by generating random numbers using a computer program. The number of sample
Sponsors
Udayana University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: For the interventional trial: 1. New patients who are diagnosed with early pulmonary TB based on records registered with TB in the health center and have never received OAT 2. Patients diagnosed with pulmonary tuberculosis, the treatment has not yet passed the two-month treatment period (intensive phase), seen from the records in the public health center TB register 3. Based on the register, the patient was diagnosed with pulmonary TB through a bacteriological examination (positive smear) using the Molecular Rapid Test (TCM) 4. Adult patients aged 18 - 65 years For qualitative data collection: 1. Patients who have received HBM-based MI intervention 1.1. Non-compliance with taking medication 1.2. Failure in treatment 1.3. Able to communicate well and willing to be informants. 1.4. Own and be able to use a smartphone 1.5. Willing to be interviewed using online media via telephone/video call for approximately 30 minutes 2. Officer/counsellor 2.1. Easy contact to communicate 2.2. Own and be able to use a smartphone 2.3. Able to communicate well and willing to be informants 2.4. Willing to be interviewed using online media via telephone/video call for approximately 30 minutes
Exclusion criteria
Exclusion criteria: For interventional trial: 1. MDR TB patients who are registered in the TB register 2. Have other comorbidities such as diabetes mellitus, cirrhosis of the liver, hepatitis; cardiovascular disease based on the doctor's examination on the TB register 3. Patients are not willing to follow Tuberculosis treatment until the advanced phase 4. Families of sufferers do not have/are unable to use a smartphone
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Medication adherence measured using pill counts in the second, fifth and sixth months of treatment 2. Treatment success based on sputum examination data in the second, fifth and sixth months of treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Barriers to counseling efficacy identified using interviews with participants at 3-4 weeks after completion of the 6-month treatment 2. Reasons for non-adherence or treatment failure identified using interviews with participants at 3-4 weeks after completion of the 6-month treatment | — |
Countries
Indonesia
Contacts
Public ContactNi Made Parwati
Outcome results
None listed